Title: Urinalysis Test for a Compromised Gastrointestinal Tract Invention: This technology is an orally administered compound that identifies a compromised gastrointestinal tract, especially in diseases that cause "leaks" in to the blood. If the GI tract is compromised, the compound will be found in.....
[更多]
Brain penetrating behavior Brain to plasma ratio over 1.0 Similar or better potency to FDA-approved tyrosine kinase inhibitors (Erlotinib, Gefitinib, Lapatinib)
[更多]
This invention provides a method of treating nonalcoholic steatohepatits (NASH), nonalcoholic fatty liver disease (NAFLD), and/or de novo lipogenesis (DNL) in humans. This method may also be used to potentially treat hepatocellular carcinoma.
[更多]
| |<首頁 <-上一頁 下一頁-> 末頁>| |
